Cited by 548Multiple Sclerosis Research StudiesPsoriasis: Treatment and PathogenesisPolyomavirus and related diseases

The DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

Ramagopalan, Sreeram V, Dobson, Ruth, Meier, Ute C, Giovannoni, Gavin·2010·The Lancet Neurology

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is a common, complex neurological disease. The precise aetiology of MS is not yet known, although epidemiological data indicate that both genetic and environmental factors are important. The evidence that the environment acts long before MS becomes clinically evident is well established and suggests the existence of a prodromal phase for the disease. The increasing incidence of MS emphasises the need for strategies to prevent this chronic disorder, and the possibility of a prodrome indicates a window of opportunity to potentially reverse early disease processes before clinical disease becomes evident. Studying a prodrome requires techniques other than clinical observation such as monitoring endophenotypes that result from associated risk factors. However, our current knowledge of causal pathways and endophenotypes in MS is limited. Identifying and studying individuals with a high risk of developing the disease provides a powerful opportunity to understand the MS causal cascade and is highly relevant to strategies that are aimed at preventing this debilitating disease.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(10)70094-6

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Vitamin D Deficiency
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., LUBLIN, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,433
Multiple Sclerosis
Noseworthy, J. H., Lucchinetti, C. F., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 3,016
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
A Population-Based Study
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,899
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Sex differences in autoimmune disease
Whitacre, C. C. (2001) · Nature Immunology · doi:10.1038/ni0901-777 · Cited by 1,294
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251

Show all 155 references

Sorted by citations

Items 301–400 of 548

Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis
Bashamakh, L. F., Alsharif, S. M., Wayyani, L. A., Alghamdi, A., Fatani, G. M., Alnajashi, H. A., & Alshamrani, F. (2019) · Neurosciences · doi:10.17712/nsj.2019.4.20190027 · Cited by 8
Effect of teriflunomide on Epstein–Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study
Gold, J., Holden, D., Parratt, J. D. E., Yiannikas, C., Ahmad, R., Sedhom, M. A. K., & Giovannoni, G. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104377 · Cited by 8
The Value of Various Post-Processing Modalities of Diffusion Weighted Imaging in the Detection of Multiple Sclerosis
Alghamdi, A. J. (2023) · Brain Sciences · doi:10.3390/brainsci13040622 · Cited by 8
Trastornos relacionados con el gluten y enfermedades desmielinizantes
Hernández‐Lahoz, C., & Rodrigo, L. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.07.009 · Cited by 8
Quantification of Brain Lesions in Multiple Sclerosis Patients using Segmentation by Convolutional Neural Networks
de Oliveira, M., Santinelli, F. B., Piacenti‐Silva, M., Rocha, F. C. G., Barbieri, F. A., Lisboa‐Filho, P. N., Santos, J. M., & Cardoso, J. S. (2020) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm49941.2020.9313244 · Cited by 8
Multiple sclerosis: what have we learned and can we still learn from electron microscopy
Oost, W., Meilof, J. F., & Baron, W. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05690-0 · Cited by 7
Microbiota-Derived SCFAs in Multiple Sclerosis: From Immune Priming to Neurodegeneration
Sharma, V. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05348-9 · Cited by 7
Effects of mindfulness-based interventions on cognition in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials
Komar, A., Dickson, K., Alavinia, M., Bruno, T. R., Bayley, M. T., Feinstein, A., Scandiffio, J., & Simpson, R. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1339851 · Cited by 8
The Multiple Sclerosis Prodrome in a Retrospective Pediatric Cohort
Barter, K. M., Sharayah, S., Mange, U., Gaudioso, C., Schanzer, N., Keuchel, C., Zolno, R., & Mar, S. (2024) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2024.09.005 · Cited by 7
No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India
Zahoor, I., Asimi, R., & Haq, E. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.11.011 · Cited by 7
Associations of HLA DRB1 Alleles with Igg Oligoclonal Bands and Their Influence on Multiple Sclerosis Course and Disability Status
Rastenyte, R. B. D. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000273 · Cited by 7
Multiple Sclerosis and Related Disorders
Fox, R. J., Rae-Grant, A. D., Béthoux, F., Phillips, J. T., Murray, T. J., Rae-Grant, A. D., Fox, R. J., Mahajan, K. R., Mahad, D., Koch, M. W., et al. (2018) · Springer Publishing Company eBooks · doi:10.1891/9780826125941 · Cited by 7
Association between vaccination and the risk of central demyelination: results from a case-referent study
Grimaldi‐Bensouda, L., Papeix, C., Hamon, Y., Bénichou, J., & Abenhaim, L. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11822-y · Cited by 13
How can proteomics elucidate the complexity of multiple sclerosis?
Farias, A. S., & dos Santos, L. M. B. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400171 · Cited by 7
Promising Emerging Therapies for Multiple Sclerosis
Giovannoni, G. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.01.003 · Cited by 7
Serostatus of Epstein–Barr virus in Iranian MS patients
Karampoor, S., Zahednasab, H., Pirkouh, A. A., Monavari, S. H., Ramagopalan, S. V., & Keyvani, H. (2015) · Acta Neurologica Belgica · doi:10.1007/s13760-015-0496-y · Cited by 7
Serum Vitamin D Level among Multiple Sclerosis Patients in the Tropics: Experience from a Private Clinic in Addis Ababa, Ethiopia
Ayele, B. A., Zebenigus, M., Zenebe, B. G., & Metaferia, G. Z. (2021) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v31i3.18 · Cited by 7
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy
Jamróz-Wiśniewska, A., Bełtowski, J., Stelmasiak, Z., & Bartosik-Psujek, H. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12000 · Cited by 7
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Disanto, G., & Ramagopalan, S. V. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512440833 · Cited by 7
The immunomodulatory effects of all-trans retinoic acid and docosahexaenoic acid combination treatment on the expression of IL-2, IL-4, T-bet, and GATA3 genes in PBMCs of multiple sclerosis patients
Nasl‐Khameneh, A. M., Mirshafiey, A., Moghadasi, A. N., Yekaninejad, M. S., Parastouei, K., Nejati, S., & Saboor-Yaraghi, A. A. (2023) · Neurological Research · doi:10.1080/01616412.2022.2162222 · Cited by 6
Molecular dynamics simulation of wild and mutant proteasome subunit beta type 8 (PSMB8) protein: Implications for restoration of inflammation in experimental autoimmune encephalomyelitis pathogenesis
Paul, S. K., Saddam, M., Tabassum, N., & Hasan, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41166 · Cited by 7
Chronic Cerebrospinal Venous Insufficiency as a Cause of Multiple Sclerosis: Controversy and Reality
Diaconu, C. I., Conway, D. S., Fox, R. J., & Rae-Grant, A. D. (2012) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-012-0168-7 · Cited by 6
Multiple Sclerosis in Women
Hayes, C. E., & Spanier, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805298-3.00010-4 · Cited by 6
Multiple Sclerosis and EIF2B5: A Paradox or a Missing Link
Zahoor, I., Haq, E., & Asimi, R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47861-6_5 · Cited by 6
An ecological study of industry in a high-risk region of multiple sclerosis
Boström, I., Landtblom, A., & Lauer, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.005 · Cited by 6
Effect of whole body cryotherapy on uric acid concentration in plasma of multiple sclerosis patients
Kopernik, M. (2011) · Cited by 6
Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status
Balnytė, R., Rastenytė, D., Vaitkus, A., Skrodenienė, E., Vitkauskienė, A., & Ulozienė, I. (2016) · Medicina · doi:10.1016/j.medici.2016.07.004 · Cited by 6
Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis
Mohammadi, S. M., Shirvani-Farsani, Z., Dosti, R., Sahraian, M. A., & Behmanesh, M. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.08.004 · Cited by 6
Prognostic Factors for Recovery of Vision in Canine Optic Neuritis of Unknown Etiology: 26 Dogs (2003–2018)
Posporis, C., Beltrán, E., Dunning, M., Espadas, I., Gillespie, S., Barry, A. T., & Wessmann, A. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00415 · Cited by 8
Hospital diagnosed pneumonia before age 20 years and multiple sclerosis risk
Smith, K. A., Hiyoshi, A., Burkill, S. M., Bahmanyar, S., Öckinger, J., Alfredsson, L. S., Olsson, T. P., & Montgomery, S. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000044 · Cited by 6
Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population
Sezer, E., Demirdöğen, B. C., Demirkaya, Ş., Bulut, G., Akkulak, M., Evin, E., & Adalı, O. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05597-1 · Cited by 8
The Application of Consensus Weighted Gene Co-expression Network Analysis to Comparative Transcriptome Meta-Datasets of Multiple Sclerosis in Gray and White Matter
Chai, K., Zhang, X., Tang, H., Gu, H., Ye, W., Wang, G., Chen, S.-F., Wan, F., Liang, J., & Shen, D. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.807349 · Cited by 6
Air pollution and multiple sclerosis risk
Giovannoni, G., Hawkes, C. H., Lechner‐Scott, J., Levy, M., & Pohl, D. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102797 · Cited by 6
Natural language processing analysis of the theories of people with multiple sclerosis about causes of their disease
Haag, C., Steinemann, N., Ajdacic‐Gross, V., Schlomberg, J. T., Ineichen, B. V., Stanikić, M., Dressel, H., Daniore, P., Roth, P., Ammann, S., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00546-3 · Cited by 5
Gut Microbiome Signatures in Multiple Sclerosis: A Case-Control Study with Machine Learning and Global Data Integration
Neklesova, M. V., Sogomonyan, K. S., Golovkin, I. A., Shirokiy, N. I., Vershinina, S. O., Tsvetikova, S. A., Korzhova, J. E., Zakharova, M. N., & Gnedovskaya, E. V. (2025) · Biomedicines · doi:10.3390/biomedicines13081806 · Cited by 6
The effect of hydrotherapy on the symptoms and functional characteristics of multiple sclerosis patients
Bekiari, M., Iakovidis, P., Lytras, D., Chatziprodromidou, I. P., & Dimitros, E. (2021) · International Journal of Physical Education Sports and Health · doi:10.22271/kheljournal.2021.v8.i2c.2050 · Cited by 5
Noninfectious Central Nervous System Inflammatory Disorders
Makhani, N., & Banwell, B. (2011) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2011.05.005 · Cited by 5
Russell W Brain and the aetiology of multiple sclerosis--a historical perspective
Pakpoor, J., & Ramagopalan, S. V. (2014) · QJM · doi:10.1093/qjmed/hcu001 · Cited by 5
Frequency of HLA-DRB1 Gene Alleles in Patients With Multiple Sclerosis in a Lithuanian Population
Balnytė, R., Rastenytė, D., Mickevičienė, D., Vaitkus, A., Skrodenienė, E., & Vitkauskienė, A. (2012) · Medicina · doi:10.3390/medicina48010002 · Cited by 5
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency
Cardaioli, G., Filippo, M. D., Bianchi, A., Eusebi, P., Gregorio, M. D., Gaetani, L., Gallina, A., Calabresi, P., & Sarchielli, P. (2016) · European Neurology · doi:10.1159/000445540 · Cited by 5
Human Immunodeficiency Virus and Multiple Sclerosis Risk: Probing for a Connection
Zahoor, M. K. I. (2015) · Journal of Multiple Sclerosis · doi:10.4172/2376-0389.1000141 · Cited by 5
Relationship between medical history and multiple sclerosis: A-case-control study
Esfandiari, F., Ghazaiean, M., Darvishi‐Khezri, H., & Baghbanian, S. M. (2023) · Medicine · doi:10.1097/md.0000000000033906 · Cited by 5
RNAi-mediated knockdown of VDR surprisingly suppresses cell growth in Jurkat T and U87-MG cells
Shirvani-Farsani, Z., & Behmanesh, M. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02837 · Cited by 5
Relationship between NF-κB1 −94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients
Zahednasab, H., Mesbah‐Namin, S. A., Sahraian, M. A., Balood, M., & Doosti, R. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.014 · Cited by 5
Medicines Used for Multiple Sclerosis – A Health Technology Assessment
Couto, E., Hamidi, V., Ringerike, T., Odgaard‐Jensen, J., Harboe, I., & Klemp, M. (2016) · NORA - Norwegian Open Research Archives · Cited by 5
Wartime stress and relapse risk in people with multiple sclerosis: a prospective cohort study
Aloni, R., Dror, C., Barazani, T., & Kalron, A. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13366-9 · Cited by 4
Optical Coherence Tomography Angiography: Revolutionizing Clinical Diagnostics and Treatment in Central Nervous System Disease
Shen, Z., Zhang, S., Yu, W., Yue, M., & Hong, C. (2024) · Aging and Disease · doi:10.14336/ad.2024.0112 · Cited by 6
Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis
Chu, D. T., Rosso, M., Gonzalez, C. T., Saxena, S., Healy, B. C., Weiner, H. L., & Chitnis, T. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102910 · Cited by 4
Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing–remitting multiple sclerosis patients and their first-degree family
Samangooei, M., Farjam, M., Niknam, Z., Etemadifar, M., Meshkibaf, M. H., & Noroozi, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00758-9 · Cited by 4
Environmental Risk Factors in Multiple Sclerosis: A Narrative Review
Saadat, S., & Saberi, A. (2022) · Journal of Guilan University of Medical Sciences · doi:10.32598/jgums.31.2.1374.2 · Cited by 4
Mesenchymal Stem Cells as A New Approach for the Treatment of Multiple Sclerosis: A Literature Review
Jafarinia, M., Rostami, A., Abbasi, Y., Asadian, A., Enani, H., & Jamalnia, S. (2022) · Galen Medical Journal · doi:10.31661/gmj.v11i.2529 · Cited by 4
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets
Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 6
The Future of PET Imaging in Multiple Sclerosis: Characterisation of Individual White Matter Lesions
van der Weijden, C. W. J., Meilof, J. F., van der Hoorn, A., de Vries, E. F. J., & Baron, W. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134439 · Cited by 4
Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis
Aldrete–Cortez, V., Duriez-Sotelo, E., Carrillo‐Mora, P., & Pérez-Zuno, J. A. (2013) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.10.002 · Cited by 4
Functioning Profiles of Young People with MS in Inpatient Rehabilitation: Data from the National Rehabilitation Reporting System in Canada
Ow, N., Mate, K., Hum, S., & Mayo, N. E. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102418 · Cited by 4
Fatigue and Functional Independence in People with Multiple Sclerosis
Buitrago, J. J., & Pérez-Parra, J. E. (2021) · Salud Uninorte · doi:10.14482/sun.37.1.616.544 · Cited by 4
Navigating the “liberation procedure”: a qualitative study of motivating and hesitating factors among people with multiple sclerosis
Ploughman, M., Harris, C. A., Hogan, S., Murray, C. L., Murdoch, M., Austin, M., & Stefanelli, M. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s65483 · Cited by 4
Seasonal variations of 25-OH vitamin D serum levels in Multiple Sclerosis patients with relapse using MRI
Sistani, S. S., Moghtaderi, A., Dashipoor, A., Ghaffarpoor, M., & Ghahderijani, B. H. (2019) · European Journal of Translational Myology · doi:10.4081/ejtm.2019.8361 · Cited by 4
PET Imaging in Multiple Sclerosis
van der Weijden, C. W. J., Meilof, J. F., & de Vries, E. F. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_33 · Cited by 4
Multiple Sclerosis
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00007-0 · Cited by 4
Do prodrome symptoms influence multiple sclerosis disease course and severity?
Vienažindytė, I., Cesarskaja, J., Vaičiulytė, D., Balnytė, R., & Matijošaitis, V. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110888 · Cited by 4
Cos’è la sclerosi multipla
Bertolotto, A., & Caricati, E. (2012) · Springer eBooks · doi:10.1007/978-88-470-2724-4_1 · Cited by 4
Vitamin A: yet another player in multiple sclerosis pathogenesis?
Filippi, M., Preziosa, P., & Rocca, M. A. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.105 · Cited by 4
Concealed effects of gene–environment interactions in genome-wide association
Handel, A. E., Williamson, A. J., & Ramagopalan, S. V. (2011) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2011.08.005 · Cited by 4
MR venography in children and adolescents with multiple sclerosis does not show increased prevalence of extracranial veins anomalies
Jurkiewicz, E., Kotulska, K., Nowak, K., Chełstowska, S., Armata, M., Chmielewski, D., & Bilska, M. (2013) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2013.11.013 · Cited by 4
The Potential of Human Amnion Epithelial Cells as an Immunomodulatory and Neuroregenerative Treatment for Multiple Sclerosis
McDonald, C., Short, M. A., Jenkin, G., & Bernard, C. C. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1118-9_21 · Cited by 4
Early hematopoiesis in multiple sclerosis patients
Jons, D., Kneider, M., Fogelstrand, L., Jeppsson, A., Jacobsson, S., & Andersen, O. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.09.004 · Cited by 4
Intrathecal immunoreactivity in people with or without previous infectious mononucleosis
Jons, D., Zetterberg, H., Malmeström, C., Bergström, T. B., Axelsson, M., Blennow, K., Thulin, M., Sundström, P., & Andersen, O. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13280 · Cited by 4
Investigation of Chlamydia pneumoniae Infection in Patients With Multiple Sclerosis: A Case-Control Study
Kazemi, S., Aghaee, B. L., Soltanian, A. R., Mazdeh, M., Taheri, M. N., & Alikhani, M. Y. (2020) · Avicenna Journal of Clinical Microbiology and Infection · doi:10.34172/ajcmi.2020.08 · Cited by 4
Dissecting the familial risk of multiple sclerosis
Hardy, J., & Thompson, A. J. (2010) · Annals of Neurology · doi:10.1002/ana.22353 · Cited by 4
Beyond the 2024 McDonald criteria for defining and diagnosing multiple sclerosis
Giovannoni, G., Thompson, E. J., Cutter, G., Rudick, R. A., & Chamoun, V. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107132 · Cited by 4
An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis
Menestrina, L., & Recanatini, M. (2022) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2022.100042 · Cited by 3
Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells
Rivera, F. J., Kraus, J., Steffenhagen, C., Küry, P., Weidner, N., & Aigner, L. (2011) · Current Signal Transduction Therapy · doi:10.2174/157436211797483994 · Cited by 3
Blood-Brain Barrier Disruption in Multiple Sclerosis
van Doorn, R. (2015) · CRC Press eBooks · doi:10.1201/b19299-4 · Cited by 3
Multiple sclerosis in Kashmir: Where we stand
Zahoor, I., Haq, E., & Asimi, R. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.042 · Cited by 3
The epigenetics of multiple sclerosis
Christensen, T., & Muchardt, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813796-3.00005-5 · Cited by 3
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
Pantzaris, M., Bakirtzis, C., Grigoriadis, N., Hadjigeorgiou, G. M., Dardiotis, E., Loucaides, G., Ntzani, E., Markozannes, G., Omorfos, S., Valsasina, P., et al. (2022) · BMJ Neurology Open · doi:10.1136/bmjno-2022-000334 · Cited by 3
Diagnose und Therapie der Multiplen Sklerose
Möhn, N., Grote-Levi, L. M., & Skripuletz, T. (2022) · Neurologie up2date · doi:10.1055/a-1724-2083 · Cited by 3
Familial versus sporadic multiple sclerosis in Palestine: a retrospective cross-sectional pilot study
Jbara, A., Saidi, I., Ishtayah, M., Ghanim, M. A., Al-Othman, N., & Rabayaa, M. (2023) · Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal · doi:10.59049/2790-0231.1138 · Cited by 3
Quality of life in patients with multiple sclerosis
Hudáková, A., Majerníková, Ľ., & Obročníková, A. (2023) · Kontakt · doi:10.32725/kont.2023.031 · Cited by 3
Healthy birth after use of sperm from a male who suffered from copper toxicity
Javed, M., & Michael, E. (2014) · Cureus · doi:10.7759/cureus.180 · Cited by 3
Can tetracyclines ensure help in Multiple Sclerosis immunotherapy?
Costa, P. V. D. C., Thomé, R., & Rapôso, C. (2021) · Journal of Clinical and Translational Research · doi:10.18053/jctres.07.202101.010 · Cited by 3
C1-C2 X-Ray assessment of misalignment parameters in patients with Chronic Cerebra-spinal Venous Insufficiency and Multiple Sclerosis versus patients with other pathologies.
Mandolesi, S., Marceca, G., d'Alessandro, A., Desogus, A. I., Ciccone, M. M., Zito, A., Manconi, E., Niglio, T., Mandolesi, D., d'Alessandro, A., et al. (2015) · PubMed · Cited by 3
Effects of the Bacillus Calmette-Guérin (BCG) Vaccine in the Demyelinating Disease of the Central Nervous System
Ristori, G., Romano, S., Cannoni, S., Buttinelli, C., Coarelli, G., Vanacore, N., Pozzilli, C., & Salvetti, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-799964-7.00005-3 · Cited by 3
Correlación entre las lesiones desmielinizantes y el deterioro de las funciones ejecutivas en una muestra de pacientes mexicanos con esclerosis múltiple
Aldrete–Cortez, V., Duriez-Sotelo, E., Carrillo‐Mora, P., & Pérez-Zuno, J. A. (2012) · Neurología · doi:10.1016/j.nrl.2012.10.005 · Cited by 3
Childhood CNS inflammatory demyelinating diseases
Absoud, M., & Wassmer, E. (2010) · Paediatrics and Child Health · doi:10.1016/j.paed.2010.05.002 · Cited by 3
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis
Balood, M., Mesbah‐Namin, S. A., Sanati, M. H., Zahednasab, H., Sahraian, M. A., & Ataei, M. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2898-3 · Cited by 3
Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice.
Shang, S.-Q., Li, J., Li, S., & Cao, Y. (2015) · PubMed Central · Cited by 3
Knowledge of pregnant women towards multiple sclerosis
Abbasi, V., Tabrizian, S., Atalu, A., Aslanian, R., & Zakeri, A. (2018) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20184772 · Cited by 6
The Gray Degeneration of the Brain and Spinal Cord
Ganesh, A., & Stahnisch, F. W. (2019) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001002 · Cited by 3
Sexual Satisfaction in Fully Ambulatory People with Multiple Sclerosis: Does Disability Matter?
Dobrakowski, P. P., Machowska-Majchrzak, A., Labuz-Roszak, B. M., Niewiadomska, E., & Pierzchała, K. (2020) · Behavioural Neurology · doi:10.1155/2020/8857516 · Cited by 3
Multiple Sclerosis
Kira, J., & Isobe, N. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_15 · Cited by 4
Month of birth and level of insolation as risk factors for multiple sclerosis in Poland
Dobrakowski, P. P., Bogocz, M., Cholewa, K., Rajchel, M., Kapica-Topczewska, K., Wawrzyniak, S., Bartosik-Psujek, H., Kułakowska, A., Koziarska, D., & Adamczyk-Sowa, M. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175156 · Cited by 3
Polymorphisms in CLOCK and ARNTL/BMAL-1 genes in multiple sclerosis: a systematic review and meta-analysis
Oladghaffari, M., Bandehagh, H., Malekinejad, F., Fakhkhari, S., Koohi, N., Moghaddamziabari, S., Hamzehzadeh, S., Mohammadian, E., Talebi, M., Salehi-Pourmehr, H., et al. (2026) · European journal of medical research · doi:10.1186/s40001-025-03798-4 · Cited by 2
Farmacoutilizzazione e considerazioni economiche nella terapia della sclerosi multipla: il ruolo della Received Daily Dose
Santoleri, F., Sorice, P., Carloni, A., Vita, F. D., Belfiglio, M., & Costantini, A. (2012) · PharmacoEconomics Italian Research Articles · doi:10.1007/bf03320693 · Cited by 2
Application of Interferon Beta-1b in Multiple Sclerosis
Bagnato, F. R. (2011) · European Neurological Review · doi:10.17925/enr.2011.06.01.36 · Cited by 2
Recent advances in the management of multiple sclerosis
Deva, R., & Rajendran, P. (2022) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20221826 · Cited by 1
The prevalence of sexual dysfunction and its contributors among the women with multiple sclerosis
Mozhdehipanah, H., Sharifi, N., Emami, A., Abbaslou, M. A., & Mirzadeh, M. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03653-y · Cited by 2
Novel insights into vascular dysfunction in cuprizone-induced demyelination through functional ultrasound imaging
Beliard, B., Delay, L., Travert-Jouanneau, Y., Travert-Jouanneau, Y., Ialy-Radio, N., Goazigo, A. R.-L., Deffieux, T., Bradley, D. P., Tanter, M., & Pezet, S. (2025) · Imaging Neuroscience · doi:10.1162/imag_a_00534 · Cited by 2
Cardiometabolic Risk, Inflammation, and Neurodegenerative Disorders
Palavra, F., Ciampi, E., & Sena, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-16018-4_7 · Cited by 2

Authors: Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G.
Affiliations: Centre for Human Genetics (GB)
Queen Mary University of London (GB)
Corresponding author: Giovannoni, Gavin
ORCID: Ramagopalan, Sreeram V
Dobson, Ruth
Meier, Ute C
Giovannoni, Gavin
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2010-07
Volume: 9
Issue: 7
Pages: 727-739
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(10)70094-6
OpenAlex: W2149134458
Cited by: 548
References: 155
Citations by year: 2026: 18 · 2025: 25 · 2024: 19 · 2023: 33 · 2022: 38 · 2021: 33 · 2020: 32 · 2019: 36 · 2018: 24 · 2017: 39 · 2016: 39 · 2015: 31 · 2014: 38 · 2013: 41 · 2012: 49
FWCI: 5.57
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Rea Charitable Trust
Medical Research Council
National Multiple Sclerosis Society
Aims2Cure
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
Keywords: multiple sclerosis, risk factors, prodromal symptoms, etiology, causal pathways, endophenotypes, genetic factors, environmental factors, disease prevention, MS incidence
MeSH terms: Disease Susceptibility, Environment, Environmental Exposure, Humans, Multiple Sclerosis, Risk Factors, Sex Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks